Reclast
zoledronic acid
- Strength
- 5 mg/100mL
- Form
- Injection, Solution
- Class
- Bisphosphonate
Sandoz Inc
Listed by BluePoint Laboratories
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Bisphosphonate |
| Approval route | ANDA — approved generic |
| NDC code | 68001-610 |
| FDA application | ANDA201783 |
| RxNorm concept | 351114 |
| Package sizes listed | 1 |
| Marketed since | February 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
zoledronic acid
Sandoz Inc
Accord Healthcare Inc.
BluePoint Laboratories
Mylan Institutional LLC
Meitheal Pharmaceuticals Inc.
Dr. Reddy's Laboratories Inc
BPI Labs LLC
Fresenius Kabi USA, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.